<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T13:47:29+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>首款且唯一，欧盟委员会批准首款CD123靶向疗法上市</title>
    <updated>2021-01-22T12:28:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/8nUutbkFjV9nH1WgBtXJGQ</id>
    <link href="https://mp.weixin.qq.com/s/8nUutbkFjV9nH1WgBtXJGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明康德2020年净利润同比增长50％到60％，海外客户订单较快增长</title>
    <updated>2021-01-22T12:28:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/xiqgga8Qpfhf6v2PaOzhkw</id>
    <link href="https://mp.weixin.qq.com/s/xiqgga8Qpfhf6v2PaOzhkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>风险降低80%：礼来Bamlanivimab预防养老人员新冠肺炎效果显著</title>
    <updated>2021-01-22T12:28:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/DQzfpk4CovJjXSm-vYqGiQ</id>
    <link href="https://mp.weixin.qq.com/s/DQzfpk4CovJjXSm-vYqGiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“未发现有造假”，科技部通报论文造假调查情况</title>
    <updated>2021-01-22T12:28:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/kOT1YCetSNjC_QdqbN_HgA</id>
    <link href="https://mp.weixin.qq.com/s/kOT1YCetSNjC_QdqbN_HgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>拜登的“战时抗疫计划”，上任两天连发14条疫情防控行政令</title>
    <updated>2021-01-22T12:28:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/m8xDAkCk3G3Ws0XXPE6BOQ</id>
    <link href="https://mp.weixin.qq.com/s/m8xDAkCk3G3Ws0XXPE6BOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>股价上涨200％，Aclaris类风湿关节炎新药临床试验获积极数据</title>
    <updated>2021-01-21T13:12:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/Ug8fb605gXeBvvR0g6UHvg</id>
    <link href="https://mp.weixin.qq.com/s/Ug8fb605gXeBvvR0g6UHvg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《2021版生物制药小编精选文章汇编》 发布！还有有机会见到你最好奇的小编</title>
    <updated>2021-01-21T13:12:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/_Wlxjzzqe1Dzh5a-MhUT8Q</id>
    <link href="https://mp.weixin.qq.com/s/_Wlxjzzqe1Dzh5a-MhUT8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10年来首个！HER2靶向药物Enhertu获FDA批准用于胃癌患者</title>
    <updated>2021-01-21T13:12:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/4JhWfI0qSPnsuANecJHs5w</id>
    <link href="https://mp.weixin.qq.com/s/4JhWfI0qSPnsuANecJHs5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021上半年10项值得关注的临床研究</title>
    <updated>2021-01-20T12:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/n937CPQFDaGaI_-ZEkKvOA</id>
    <link href="https://mp.weixin.qq.com/s/n937CPQFDaGaI_-ZEkKvOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD47-SIRPα轴肿瘤免疫疗法-靶向SIRPα</title>
    <updated>2021-01-20T12:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/NV_M3jhBJtcqxHHYgXmXSQ</id>
    <link href="https://mp.weixin.qq.com/s/NV_M3jhBJtcqxHHYgXmXSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>美国总统交接前夜，这是你在白宫之外能看到最全面的【曲速行动】</title>
    <updated>2021-01-20T12:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/_SJ2HzM3WyP9BAgQazzCMA</id>
    <link href="https://mp.weixin.qq.com/s/_SJ2HzM3WyP9BAgQazzCMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双抗领域新动向，礼来与Merus达成16亿美元合作</title>
    <updated>2021-01-20T12:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/_4yJUFH3djY6C_HYxfFrsQ</id>
    <link href="https://mp.weixin.qq.com/s/_4yJUFH3djY6C_HYxfFrsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>勃林格殷格翰与克睿基因合作开发新型AAV载体，用于下一代基因治疗</title>
    <updated>2021-01-20T12:05:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/eWTClWSUB7w2QuBIb0j4ng</id>
    <link href="https://mp.weixin.qq.com/s/eWTClWSUB7w2QuBIb0j4ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年基因治疗领域面临的五大问题</title>
    <updated>2021-01-19T11:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/Tb48C_fL46vhU7Fqx8LSCg</id>
    <link href="https://mp.weixin.qq.com/s/Tb48C_fL46vhU7Fqx8LSCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首批嘉宾阵容揭晓！细胞基因全产业链梳理，精选对话尽在2021年TG-Bio</title>
    <updated>2021-01-19T11:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/mEfmxd0Dyjniiy_qqeTTBQ</id>
    <link href="https://mp.weixin.qq.com/s/mEfmxd0Dyjniiy_qqeTTBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>里程碑：我国首个基因编辑疗法获批临床</title>
    <updated>2021-01-19T11:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/9s9o4aHxscfoXRyiXGaRhQ</id>
    <link href="https://mp.weixin.qq.com/s/9s9o4aHxscfoXRyiXGaRhQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个通用CAR-T 产品启动临床，来自亘喜生物</title>
    <updated>2021-01-19T11:49:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/yXYcJbVVrzlBab3qJcGuHA</id>
    <link href="https://mp.weixin.qq.com/s/yXYcJbVVrzlBab3qJcGuHA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>查尔斯河实验室与驾玉生物合作，扩大生物制药服务的能力</title>
    <updated>2021-01-18T12:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/624ekFvBPi2sCbnlIi3S6Q</id>
    <link href="https://mp.weixin.qq.com/s/624ekFvBPi2sCbnlIi3S6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年值得关注的5大生物技术交易趋势</title>
    <updated>2021-01-18T12:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/jfEsp_ICPa4RQFwL56gQjA</id>
    <link href="https://mp.weixin.qq.com/s/jfEsp_ICPa4RQFwL56gQjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>涨108%！科创板正式迎来“新冠核酸第1证”企业</title>
    <updated>2021-01-18T12:27:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/IfLIPQrv8o0vOh8g0NOP2g</id>
    <link href="https://mp.weixin.qq.com/s/IfLIPQrv8o0vOh8g0NOP2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>